Perceptive Capital Solutions Corp (NASDAQ: PCSC) is a blank check special purpose acquisition company (SPAC) formed to identify and complete a merger or acquisition with a target business in the life sciences and healthcare sector. The company generates no operating revenue. Its sole activity is identifying a business combination target, with $86,250,000 in gross IPO and private placement proceeds held in a Trust Account managed by Continental Stock Transfer and Trust Company as of the IPO closing date of June 13, 2024. PCSC is sponsored by an affiliate of Perceptive Advisors, a healthcare-focused investment firm with over $9.5 billion in regulatory assets under management as of December 31, 2025. The company has proposed a business combination with Freenome, a private life sciences company, under the Proposed Freenome Business Combination Agreement. PCSC must complete an initial business combination by June 13, 2026, or liquidate and return trust funds to shareholders. Joseph Edelman serves as Chairman and Adam Stone serves as CEO. The company was incorporated in 2024 with inception on March 22, 2024.

Revenue model

PCSC has no operating revenues as of its 10-K filed 2026-03-12. The trust account earns interest on the $86,250,000 deposited at IPO close (June 13, 2024). Value to sponsors is realized only upon completion of an initial business combination.

Products and services

PCSC offers no products or services. It issued 8,625,000 Class A ordinary shares at $10.00 per share in its IPO (June 13, 2024), including 1,125,000 shares from the underwriter over-allotment option, and 286,250 Class A ordinary shares in a concurrent private placement to its sponsor at $10.00 per share.

Customers and end markets

PCSC's end market focus is life sciences and healthcare, consistent with its sponsor Perceptive Advisors, which has investments in 234 companies as of December 31, 2025. Public shareholders are the primary capital providers, with redemption rights tied to the trust account balance.

Value-chain role

PCSC is a capital formation vehicle. It aggregates public capital into a trust account and deploys it via a negotiated business combination with a private or public target. Jefferies LLC served as underwriter for the IPO.

Geographic exposure

PCSC is incorporated as a Cayman Islands entity. Its proposed combination target Freenome is a U.S.-based company. The filing notes potential for targets with operations outside the United States.

Source: SEC 10-K, filed 2026-03-12

Industry: Services-Medical Laboratories